Market Research Life Sciences Market Research Pharmaceuticals Market Research Therapeutic Area Market Research Oncology/Hematology Market Research

Global Chronic Myeloid Leukemia Market and Competitive Landscape – 2017

Best Price Guarantee Publisher Published Date SKU
from $3,990 Fore Pharma August, 2017 FPCI15450599
Best Price Guarantee
Price from $3,990
Publisher Fore Pharma
Published Date August, 2017
SKU FPCI15450599

Global Chronic Myeloid Leukemia Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Global Chronic Myeloid Leukemia Market and Competitive Landscape – 2017, provides comprehensive insights into Chronic Myeloid Leukemia pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Chronic Myeloid Leukemia market size and drug sales. This research also provides insights into Chronic Myeloid Leukemia epidemiology and late stage pipeline.
The report is classified into twelve sections – Chronic Myeloid Leukemia overview with definitions, symptoms, etiology, diagnosis, treatment options; Chronic Myeloid Leukemia pipeline insights covering late stage clinical trials pipeline; Chronic Myeloid Leukemia prevalence trends by countries; Chronic Myeloid Leukemia market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries – US, Germany, France, Italy, Spain, UK, Japan, Europe, Global.

Research Scope:

  • Chronic Myeloid Leukemia pipeline: Find out the drugs in clinical trials for Chronic Myeloid Leukemia by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Chronic Myeloid Leukemia epidemiology: Find out the prevalence of Chronic Myeloid Leukemia by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Chronic Myeloid Leukemia products: Identify key products marketed and prescribed for Chronic Myeloid Leukemia by brand name, by molecule, by company, by branded / generic, by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Chronic Myeloid Leukemia market size: Find out the market size for Chronic Myeloid Leukemia drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Chronic Myeloid Leukemia drug sales: Find out the sales of Chronic Myeloid Leukemia drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
  • Chronic Myeloid Leukemia drugs sales forecast: Sales forecast for Chronic Myeloid Leukemia drugs to 2021 by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Chronic Myeloid Leukemia market share analysis: Find out the market shares of Chronic Myeloid Leukemia drugs and outlook by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Chronic Myeloid Leukemia drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Chronic Myeloid Leukemia market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Chronic Myeloid Leukemia market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


1. Chronic Myeloid Leukemia: Disease Overview
1.1. Chronic Myeloid Leukemia Symptoms
1.2. Chronic Myeloid Leukemia Etiology
1.3. Chronic Myeloid Leukemia Diagnosis
1.4. Chronic Myeloid Leukemia Treatment Options
2. Chronic Myeloid Leukemia Pipeline Insights
2.1. Chronic Myeloid Leukemia Phase 3 Clinical Trials
2.2. Chronic Myeloid Leukemia Phase 2 Clinical Trials
2.3. Chronic Myeloid Leukemia Phase 1 Clinical Trials
3. Chronic Myeloid Leukemia Epidemiology Analysis
4. US Chronic Myeloid Leukemia Market Insights
4.1. Marketed Products for Chronic Myeloid Leukemia in US
4.2. US Chronic Myeloid Leukemia Market Size & Forecast
4.3. US Chronic Myeloid Leukemia Product Sales Forecast
4.4. US Chronic Myeloid Leukemia Market Share Analysis
5. Germany Chronic Myeloid Leukemia Market Insights
5.1. Marketed Products for Chronic Myeloid Leukemia in Germany
5.2. Germany Chronic Myeloid Leukemia Market Size & Forecast
5.3. Germany Chronic Myeloid Leukemia Product Sales Forecast
5.4. Germany Chronic Myeloid Leukemia Market Share Analysis
6. France Chronic Myeloid Leukemia Market Insights
6.1. Marketed Products for Chronic Myeloid Leukemia in France
6.2. France Chronic Myeloid Leukemia Market Size & Forecast
6.3. France Chronic Myeloid Leukemia Product Sales Forecast
6.4. France Chronic Myeloid Leukemia Market Share Analysis
7. Italy Chronic Myeloid Leukemia Market Insights
7.1. Marketed Products for Chronic Myeloid Leukemia in Italy
7.2. Italy Chronic Myeloid Leukemia Market Size & Forecast
7.3. Italy Chronic Myeloid Leukemia Product Sales Forecast
7.4. Italy Chronic Myeloid Leukemia Market Share Analysis
8. Spain Chronic Myeloid Leukemia Market Insights
8.1. Marketed Products for Chronic Myeloid Leukemia in Spain
8.2. Spain Chronic Myeloid Leukemia Market Size & Forecast
8.3. Spain Chronic Myeloid Leukemia Product Sales Forecast
8.4. Spain Chronic Myeloid Leukemia Market Share Analysis
9. UK Chronic Myeloid Leukemia Market Insights
9.1. Marketed Products for Chronic Myeloid Leukemia in UK
9.2. UK Chronic Myeloid Leukemia Market Size & Forecast
9.3. UK Chronic Myeloid Leukemia Product Sales Forecast
9.4. UK Chronic Myeloid Leukemia Market Share Analysis
10. Europe Chronic Myeloid Leukemia Market Insights
10.1. Europe Chronic Myeloid Leukemia Market Size & Forecast
10.2. Europe Chronic Myeloid Leukemia Product Sales Forecast
10.3. Europe Chronic Myeloid Leukemia Market Share Analysis
11. Japan Chronic Myeloid Leukemia Market Insights
11.1. Marketed Products for Chronic Myeloid Leukemia in Japan
11.2. Japan Chronic Myeloid Leukemia Market Size & Forecast
11.3. Japan Chronic Myeloid Leukemia Product Sales Forecast
11.4. Japan Chronic Myeloid Leukemia Market Share Analysis
12. Global Chronic Myeloid Leukemia Market Insights
12.1. Global Chronic Myeloid Leukemia Market Size & Forecast
12.2. Global Chronic Myeloid Leukemia Product Sales Forecast
12.3. Global Chronic Myeloid Leukemia Market Share Analysis
13. Research Methodology
LIST OF TABLES
Table 1: Chronic Myeloid Leukemia Phase 3 Clinical Trials, Global, 2017
Table 2: Chronic Myeloid Leukemia Phase 2 Clinical Trials, Global, 2017
Table 3: Chronic Myeloid Leukemia Phase 1 Clinical Trials, Global, 2017
Table 4: Chronic Myeloid Leukemia Prevalence by G7 Countries, 2012 - 2021
Table 5: Marketed Products for Chronic Myeloid Leukemia in US, 2017
Table 6: US Chronic Myeloid Leukemia Market Size & Forecast ($mn), 2012 - 2021
Table 7: US Chronic Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Table 8: US Chronic Myeloid Leukemia Market Trends, 2012 - 2021
Table 9: Marketed Products for Chronic Myeloid Leukemia in Germany, 2017
Table 10: Germany Chronic Myeloid Leukemia Market Size & Forecast ($mn), 2012 - 2021
Table 11: Germany Chronic Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Table 12: Germany Chronic Myeloid Leukemia Market Trends, 2012 - 2021
Table 13: Marketed Products for Chronic Myeloid Leukemia in France, 2017
Table 14: France Chronic Myeloid Leukemia Market Size & Forecast ($mn), 2012 - 2021
Table 15: France Chronic Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Table 16: France Chronic Myeloid Leukemia Market Trends, 2012 - 2021
Table 17: Marketed Products for Chronic Myeloid Leukemia in Italy, 2017
Table 18: Italy Chronic Myeloid Leukemia Market Size & Forecast ($mn), 2012 - 2021
Table 19: Italy Chronic Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Table 20: Italy Chronic Myeloid Leukemia Market Trends, 2012 - 2021
Table 21: Marketed Products for Chronic Myeloid Leukemia in Spain, 2017
Table 22: Spain Chronic Myeloid Leukemia Market Size & Forecast ($mn), 2012 - 2021
Table 23: Spain Chronic Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Table 24: Spain Chronic Myeloid Leukemia Market Trends, 2012 - 2021
Table 25: Marketed Products for Chronic Myeloid Leukemia in UK, 2017
Table 26: UK Chronic Myeloid Leukemia Market Size & Forecast ($mn), 2012 - 2021
Table 27: UK Chronic Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Table 28: UK Chronic Myeloid Leukemia Market Trends, 2012 - 2021
Table 29: Europe Chronic Myeloid Leukemia Market Size & Forecast ($mn), 2012 - 2021
Table 30: Europe Chronic Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Table 31: Marketed Products for Chronic Myeloid Leukemia in Japan, 2017
Table 32: Japan Chronic Myeloid Leukemia Market Size & Forecast ($mn), 2012 - 2021
Table 33: Japan Chronic Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Table 34: Japan Chronic Myeloid Leukemia Market Trends, 2012 - 2021
Table 35: Global Chronic Myeloid Leukemia Market Size & Forecast ($mn), 2012 - 2021
Table 36: Global Chronic Myeloid Leukemia Product Sales ($mn), 2012 - 2021
LIST OF FIGURES
Figure 1: Chronic Myeloid Leukemia Pipeline by Phase (%), Global, 2017
Figure 2: Chronic Myeloid Leukemia Prevalence by G7 Countries, 2012 - 2021
Figure 3: US Chronic Myeloid Leukemia Market Size ($mn), 2012 - 2021
Figure 4: US Chronic Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Figure 5: US Chronic Myeloid Leukemia Market Share by Products (%), 2016
Figure 6: US Chronic Myeloid Leukemia Market - Future Market Share (%), 2021
Figure 7: Germany Chronic Myeloid Leukemia Market Size ($mn), 2012 - 2021
Figure 8: Germany Chronic Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Figure 9: Germany Chronic Myeloid Leukemia Market Share by Products (%), 2016
Figure 10: Germany Chronic Myeloid Leukemia Market - Future Market Share (%), 2021
Figure 11: France Chronic Myeloid Leukemia Market Size ($mn), 2012 - 2021
Figure 12: France Chronic Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Figure 13: France Chronic Myeloid Leukemia Market Share by Products (%), 2016
Figure 14: France Chronic Myeloid Leukemia Market - Future Market Share (%), 2021
Figure 15: Italy Chronic Myeloid Leukemia Market Size ($mn), 2012 - 2021
Figure 16: Italy Chronic Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Figure 17: Italy Chronic Myeloid Leukemia Market Share by Products (%), 2016
Figure 18: Italy Chronic Myeloid Leukemia Market - Future Market Share (%), 2021
Figure 19: Spain Chronic Myeloid Leukemia Market Size ($mn), 2012 - 2021
Figure 20: Spain Chronic Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Figure 21: Spain Chronic Myeloid Leukemia Market Share by Products (%), 2016
Figure 22: Spain Chronic Myeloid Leukemia Market - Future Market Share (%), 2021
Figure 23: UK Chronic Myeloid Leukemia Market Size ($mn), 2012 - 2021
Figure 24: UK Chronic Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Figure 25: UK Chronic Myeloid Leukemia Market Share by Products (%), 2016
Figure 26: UK Chronic Myeloid Leukemia Market - Future Market Share (%), 2021
Figure 27: Europe Chronic Myeloid Leukemia Market Size ($mn), 2012 - 2021
Figure 28: Europe Chronic Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Figure 29: Europe Chronic Myeloid Leukemia Market Share by Products (%), 2016
Figure 30: Europe Chronic Myeloid Leukemia Market - Future Market Share (%), 2021
Figure 31: Japan Chronic Myeloid Leukemia Market Size ($mn), 2012 - 2021
Figure 32: Japan Chronic Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Figure 33: Japan Chronic Myeloid Leukemia Market Share by Products (%), 2016
Figure 34: Japan Chronic Myeloid Leukemia Market - Future Market Share (%), 2021
Figure 35: Global Chronic Myeloid Leukemia Market Size ($mn), 2012 - 2021
Figure 36: Global Chronic Myeloid Leukemia Product Sales ($mn), 2012 - 2021
Figure 37: Global Chronic Myeloid Leukemia Market Share by Products (%), 2016
Figure 38: Global Chronic Myeloid Leukemia Market - Future Market Share (%), 2021

$3,990
$5,650

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings